A recent CDC MMWR report described the BA.3.2 SARS-CoV-2 variant, nicknamed "cicada," as a new lineage of COVD-19 virus. The ...

Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential ...

Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates ...

Plant immunity is largely initiated at the cellular level, with each cell capable of autonomous detection and response, while ...

But for Rockefeller virologist Theodora Hatziioannou, the viruses have one very important thing in common: They both cause ...

In academic and industrial protein research, speed, accuracy, and accessibility are essential. After purifying proteins using ...

Discover the science behind the sudden spread of the COVID-19 "Cicada" variant, its unique symptoms, and how it evades ...

Novel agent outperforms placebo in phase II trial, but is it enough?

XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the ...

CDC surveillance shows that the highly divergent SARS-CoV-2 variant BA.3.2 spread to at least 23 countries and was detected ...

Plant immunity is largely initiated at the cellular level, with each cell capable of autonomous detection and response, while also coordinating ...

Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to ...